Recent News

• 06.11.2025 - Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
• 05.06.2025 - Cogent Biosciences Reports First Quarter 2025 Financial Results
• 04.25.2025 - Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Recent Filings

• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - 8-K Current report
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.05.2025 - EX-99.1 EX-99.1
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.09.2025 - EFFECT Notice of Effectiveness